BRPI0414072A - composição farmacêutica e seus usos para o retardo de doenças cardiovasculares - Google Patents

composição farmacêutica e seus usos para o retardo de doenças cardiovasculares

Info

Publication number
BRPI0414072A
BRPI0414072A BRPI0414072-9A BRPI0414072A BRPI0414072A BR PI0414072 A BRPI0414072 A BR PI0414072A BR PI0414072 A BRPI0414072 A BR PI0414072A BR PI0414072 A BRPI0414072 A BR PI0414072A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
cardiovascular disease
retardation
magnesium
green tea
Prior art date
Application number
BRPI0414072-9A
Other languages
English (en)
Inventor
Matthias Rath
Aleksandra Niedzwiecki
Vadim Ivanov
Waheed M Roomi
Original Assignee
Matthias Rath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/657,019 external-priority patent/US20050053673A1/en
Application filed by Matthias Rath filed Critical Matthias Rath
Publication of BRPI0414072A publication Critical patent/BRPI0414072A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçãO FARMACêUTICA E SEUS USOS PARA O RETARDO DE DOENçAS CARDIOVASCULARES". A presente invenção fornece composições farmacêuticas que compreendem lisina, prolina, arginina, vitamina C, magnésio, extrato de chá verde, N-acetil-cisteína, selênio, cobre, manganês e um componente farmacêutico aceitável selecionado do grupo que consiste em um transportador, um diluente e um excipiente, onde a composição farmacêutica sem o componente aceitável contém 7-9% em peso de magnésio, 20-30% em peso de ácido ascórbico e 11-25% em peso extrato de chá verde. Um método de tratamento de doença cardiovascular que usa as composições farmacêuticas também é revelado, mais preferivelmente para o tratamento de mulheres na pós-menopausa.
BRPI0414072-9A 2003-09-05 2004-08-18 composição farmacêutica e seus usos para o retardo de doenças cardiovasculares BRPI0414072A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/657,019 US20050053673A1 (en) 2003-09-05 2003-09-05 Composition and method for facilitating bone healing
US10/801,262 US20050053674A1 (en) 2003-09-05 2004-03-15 Pharmaceutical composition and method for retardation of the progression of atherosclerosis
PCT/EP2004/009263 WO2005023239A1 (en) 2003-09-05 2004-08-18 Pharmaceutical composition comprising i.a. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases

Publications (1)

Publication Number Publication Date
BRPI0414072A true BRPI0414072A (pt) 2006-10-24

Family

ID=34279085

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0414072-9A BRPI0414072A (pt) 2003-09-05 2004-08-18 composição farmacêutica e seus usos para o retardo de doenças cardiovasculares

Country Status (10)

Country Link
EP (1) EP1689381B1 (pt)
JP (1) JP2008509877A (pt)
KR (1) KR20060069850A (pt)
AU (1) AU2004269872A1 (pt)
BR (1) BRPI0414072A (pt)
CA (1) CA2532161A1 (pt)
MX (1) MXPA06002534A (pt)
PL (1) PL1689381T3 (pt)
RU (1) RU2006110952A (pt)
WO (1) WO2005023239A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070122363A1 (en) * 2005-11-26 2007-05-31 Giniger Martin S Corporeal delivery of carotenoids
JP5151083B2 (ja) * 2006-07-20 2013-02-27 大正製薬株式会社 経口用組成物
KR101671959B1 (ko) * 2012-03-07 2016-11-03 주식회사 케어사이드 심장 및 간 기능 개선용 조성물 및 이를 포함하는 기능성 식품
JP6347956B2 (ja) * 2014-01-17 2018-06-27 ポーラ化成工業株式会社 経口用組成物
WO2019117702A1 (en) * 2017-12-16 2019-06-20 Kam Faii Yuen A medicament to control and reduce hypertension

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5862117A (ja) * 1981-10-07 1983-04-13 Yoshihiro Futsusa 抗動脈硬化剤
JPH0656686A (ja) * 1992-08-04 1994-03-01 Itouen:Kk 抗動脈硬化剤
AU6141498A (en) * 1997-02-04 1998-08-25 John V. Kosbab Compositions and methods for prevention and treatment of vascular degenerative diseases
US5849337A (en) * 1997-06-27 1998-12-15 Gusty Winds Corporation Method of enhancing magnesium absorption and prevention of atherosclerosis
AU6558900A (en) * 1999-08-20 2001-03-19 Ferrosan A/S A pharmaceutical delivery system for vitamin c and vitamin and use of a combination of vitamin C and E for preventing or treating conditions involving oxidative stress
PL215159B1 (pl) * 2002-01-11 2013-10-31 Matthias Rath Odzywcza kompozycja farmaceutyczna uzyteczna w leczeniu raka oraz jej zastosowanie

Also Published As

Publication number Publication date
PL1689381T3 (pl) 2010-07-30
AU2004269872A1 (en) 2005-03-17
CA2532161A1 (en) 2005-03-17
JP2008509877A (ja) 2008-04-03
WO2005023239A1 (en) 2005-03-17
EP1689381B1 (en) 2010-02-24
KR20060069850A (ko) 2006-06-22
EP1689381A1 (en) 2006-08-16
RU2006110952A (ru) 2006-08-27
MXPA06002534A (es) 2006-06-20

Similar Documents

Publication Publication Date Title
NO20061461L (no) Farmasoytisk sammensetning som blant annet omfatter vitamin C, magnesium og ekstrakt av gronn te for hemming av hjertekarsykdommer
Akanitapichat et al. Antioxidant and hepatoprotective activities of five eggplant varieties
Quiñones et al. Low-molecular procyanidin rich grape seed extract exerts antihypertensive effect in males spontaneously hypertensive rats
Liu et al. Antioxidant activity and phenolic compounds of Holotrichia parallela Motschulsky extracts
NO20060143L (no) Farmasoytisk preparat og fremgangsmate for a lindre bivirkninger av ostrogenerstatningsbehandling
Goutzourelas et al. Polyphenolic composition of grape stem extracts affects antioxidant activity in endothelial and muscle cells
Shanmugapriya et al. Antioxidant activity, total phenolic and flavonoid contents of Artocarpus heterophyllus and Manilkara zapota seeds and its reduction potential
BRPI0507593A (pt) composições contendo cis-isÈmeros de um composto carotenóide e processo
RU2007111720A (ru) Активаторы митохондрий
Ibrahim et al. Assessment of antioxidant activities in roots of Miswak (Salvadora persica) plants grown at two different locations in Saudi Arabia
RU2004124384A (ru) Обладающий питательными свойствами фармацевтический состав на основе полифенолов и его использование при лечении рака
Cunha et al. Agmatine attenuates reserpine-induced oral dyskinesia in mice: Role of oxidative stress, nitric oxide and glutamate NMDA receptors
EP1470817A4 (en) COMPOSITION AND METHOD FOR THE PREVENTION OF CANCER IN HUMAN SUBJECTS
WO2003086329A8 (en) Skincare compositions comprising anti-oxidant agents
Zhang et al. 3, 5-Dicaffeoylquinic acid isolated from Artemisia argyi and its ester derivatives exert anti-leucyl-tRNA synthetase of Giardia lamblia (GlLeuRS) and potential anti-giardial effects
NO20076682L (no) Nye pyridinanaloger
MX2007013623A (es) Preparacion externa para la piel.
Tocmo et al. Organosulfide profile and hydrogen sulfide-releasing capacity of stinky bean (Parkia speciosa) oil: effects of pH and extraction methods
JP2009543756A (ja) 抗酸化活性が改善された微量養分を含有する組成物及びその使用
BRPI0414072A (pt) composição farmacêutica e seus usos para o retardo de doenças cardiovasculares
Torre et al. Evaluation of antioxidant capacity and identification of bioactive compounds of crude methanol extracts of Caesalpinia pulcherrima (L.) Swartz
Sabir et al. Antioxidant properties of β-seleno amines against lipid peroxidation in rat brain and liver
JP2014240441A (ja) アスタキサンチン含有加齢臭抑制組成物
DE602005018972D1 (de) 5,6-dimethylthienoä2,3-diüpyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung für die bekämpfung von viren
AR023219A1 (es) Combinacion de inhibidor(es) de no-sintasa y antioxidante(s) metabolico(s)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: A61K 45/06 (2006.01), A61K 31/198 (2006.01), A61K